Douglas L. Jennings, PharmD, BCPS (AQ Cardiology)

Douglas L. Jennings, PharmD, BCPS 1 Douglas L. Jennings, PharmD, BCPS (AQ Cardiology) University Office Address Department of Pharmacy Practice Nova Southeastern University 3200 S. University Drive Ft. Lauderdale, Florida 33328 Phone: 954-262-1362 Email: djennings@nova.edu Practice Site Address Department of Pharmacy Services Jackson Memorial Hospital 1611 NW 12th Avenue East Tower - B069 Miami, Florida 33136 EDUCATION 07/07 06/08 Cardiovascular Specialty Residency Program Director: James Kalus, PharmD, BCPS (AQ Cardiology) 07/06 06/07 Pharmacy Practice Residency, ASHP Accredited Medical University of South Carolina, Charleston, SC Program Director: Dominic Ragucci, PharmD, BCPS 09/03 05/05 Doctor of Pharmacy (PharmD) Wayne State University Eugene EACPHS, Detroit, MI 09/99 05/03 Bachelor of Science in Allied Health Sciences with a Concentration in Pharmaceutical Sciences, Magna Cum Laude Wayne State University EACPHS, Detroit, MI ACADEMIC APPOINTMENTS 08/13 Present Assistant Professor of Pharmacy Practice, Nova Southeastern University, Ft. Lauderdale, FL 03/09 07/13 Adjunct Assistant Professor, Department of Pharmacy Practice, Wayne State University EACPHS, Detroit, MI PROFESSIONAL EXPERIENCE Department of Pharmacy Services, Jackson Memorial Hospital, Miami, Fl 08/13 Present: Clinical Specialist Cardiac Surgery, Cardiothoracic Transplant and Mechanical Circulatory Support Department of Pharmacy Services, 12/08 07/13: Clinical Specialist - Cardiac Intensive Care Unit and Advanced Heart Failure 07/09 07/13: Clinical Specialist - Cardiothoracic ICU/Ventricular-assist Device Team 07/10 07/13: Clinical Staff Pharmacist (per diem) Inpatient Pharmacy 07/11 07/13: Program Director - Pharmacotherapy Residency 08/11 07/13: Preceptor Pharmacy Resident On call Program 07/12 07/13: Clinical Specialist Cardiothoracic Transplantation

Douglas L. Jennings, PharmD, BCPS 2 Consultant, Wolters Kluwer Health, Clinical Solutions, Lexicomp 07/12 Management of Heparin-induced Thrombocytopenia in the Cardiac Surgery Patient Published in the Anesthesiology & Critical Care Drug Handbook and the Drug Information Handbook (22nd edition) ABSTRACTS/POSTERS/ORAL PRESENTATIONS National/International Jennings DL, Brewer R, Williams CT, Morgan JA. Impact of pre-operative ACE inhibitor exposure on the incidence of intraoperative and postoperative refractory vasoplegia in patients undergoing left-ventricular assist device implantation. Oral Presentation: American Society of Artificial Internal Organs (ASAIO) 59 th Annual Meeting, Chicago, IL, 2013 Abstract Published: ASAIO Journal, 2013 Jennings DL, Chopra A, Chambers R, Williams CT, Morgan JA. Outcomes of chronic antimicrobial suppression therapy in patients with previous infection on continuous flow left ventricular device support Poster: ASAIO 59 th Annual Meeting, Chicago, IL, 2013 Abstract Published: ASAIO Journal, 2013 Jennings DL, Smith C, Williams CT. Use of pentoxiphylline for hemolytic anemia in a patient with a continuous-flow left-ventricular assist device. Poster: International Society of Heart and Lung Transplantation, 33rd Annual Meeting and Scientific Sessions, Montreal, Ca 04/2013. Abstract published: Journal of Heart and Lung Transplantation, 2013 To L, Kalus JK, Nemerovski CW, Jennings DL. Rates of readmission in patients with postoperative atrial fibrillation after cardiothoracic surgery. Poster: American Society of Health-system Pharmacy Midyear Clinical Meeting, Las Vegas, NV. 12/2012 Jennings DL, Lekura J. Ability of a clinical pharmacist to make drug therapy interventions using email in patients with advanced heart failure and ventricular-assist devices. Poster: American College of Clinical Pharmacy (ACCP) Annual Meeting, Hollywood, FL. 10/2012 Abstract published: Pharmacotherapy, 2012 Jennings DL, Sadik Z, Nemerovski CW, Kalus JS. Impact of platelet functional assays on the cost of treating suspected heparin induced thrombocytopenia (HIT). Poster: ACCP Annual Meeting, Hollywood, FL. 10/2012 Abstract published: Pharmacotherapy, 2012 Makowski CT, Chamber R, Jennings DL. Pharmacokinetics of vancomycin in patients with continuous flow left-ventricular assist devices. Poster: ACCP Annual Meeting, Hollywood, FL. 10/2012 Abstract published: Pharmacotherapy, 2012

Douglas L. Jennings, PharmD, BCPS 3 Makowski CT, Jennings DL, Nemverovski CW, Kalus JS. Patient satisfaction with an inpatient pharmacist-directed anticoagulation service. Poster: ACCP Annual Meeting, Hollywood, FL. 10/2012 Abstract published: Pharmacotherapy, 2012 Williams CT, Jennings DL, Karadolian S, Chamaria S. Analysis of cost for readmissions after continuous flow left ventricular assist device implantation: A single center experience Oral Presentation: American College of Cardiology Annual Scientific Session, Chicago, IL. 3/2012 Abstract published: J Am Coll Cardiol 2012;59(13):E1018. Jennings DL, Smith C, Brewer B, Williams CT. Opportunities for clinical pharmacist intervention in pharmacotherapy of patients with left-ventricular assist devices. Oral Presentation: ACCP Annual Meeting, Pittsburgh, PA. 10/2011 Abstract published: Pharmacotherapy, 2011 Jennings DL, Brewer B, Williams CT. Left-ventricular assist device implantation does not alter the pharmacodynamic response to warfarin. Poster: ACCP Annual Meeting, Pittsburgh, PA. 10/2011 Abstract published: Pharmacotherapy, 2011 Chamaria S, Jennings DL, Williams C. Initial clinical experience with oral sildenafil in patients with elevated pulmonary artery pressure after implantation of newer left-ventricular assist devices. Poster: American Society for Artificial Internal Organs Annual Conference, Washington, DC. 06/2011 Jones M, Lanfear D, Jennings DL. Assessment of the heart failure pharmacotherapy of patients with continuous, axial flow left ventricular assist devices. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2010 Smith Z, Jennings DL. Pharmacotherapy of patients with ST-segment elevation myocardial infarction undergoing rescue percutaneous coronary intervention. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2010 Wong J, Lulek K, Jennings DL, Nemerovski CW, Kalus JS. Assessment of antiplatelet and anticoagulant use in the cardiac catheterization laboratory. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2010 Jennings DL, McDonnell J, Schillig J. Evaluation of long-term anticoagulation in patients with left-ventricular assist devices. Poster: ACCP Annual Meeting in Austin, TX. 10/2010 Abstract Published: Pharmacotherapy, 2010 Jennings DL, Kheiri A, Kalus JS. An evaluation of employers perceptions on the value of a pharmacy resident teaching certificate program. Poster: ACCP Annual Meeting in Austin, TX. 10/2010 Abstract Published: Pharmacotherapy, 2010

Douglas L. Jennings, PharmD, BCPS 4 Gross A, Jennings DL, Fleming J, Davis S. Healthcare Associated Infection in Patients with Left Ventricular Assist Devices. Poster: The 50 th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA. 09/2010 Ma M, Jennings DL, Kalus JS. Hemodynamic and electrocardiographic effects of short-term cyanocobalamin administration on healthy volunteers. Poster: ASHP Midyear Meeting in Las Vegas, NV. 12/2009 Jennings DL, Kalus JS. Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: A meta-analysis. Oral Presentation: American Heart Association Scientific Sessions, New Orleans, LA. 11/2008 Abstract Published: Circulation, 2008 Jennings DL, Hansen L, Pallares MJ, Thompson A, Garrison K, Wessell AM. Assessment of Vitamin K Use in the Inpatient Treatment of Excessive Anticoagulation. Poster: ACCP Annual Meeting, Denver, CO. 12/2007 Abstract Published: Pharmacotherapy, 2007 Jennings DL, Ragucci KR. Diabetes Quality of Life in an Ambulatory Care Clinic. Poster: University Health system Consortium, in conjunction with the American Society of Health-System Pharmacists Midyear Clinical Meeting in Anaheim, CA. 12/2006 Manierski C, Jennings DL, Kalus JS. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A Meta-Analysis. Oral Presentation: American Society of Nephrology Renal Week in Philadelphia, PN. 11/2005 Abstract Published: J Am Soc Nephrol 2005:16 Yagman LA, Petricca JC, Jennings DL, O Dell K, Kalus JS. A Pilot Study to Evaluate Whether Patient Factors Predict Early Readmission After Acute Coronary Syndromes. Poster: ASHP Midyear Meeting in Orlando, FL. 12/2004 Abstract Published: Am J Health-Syst Pharm, 2004. Local Jennings DL, Brewer R, Williams C, Smith C. Opportunities for clinical pharmacist intervention in the pharmacotherapy of patients with left-ventricular assist devices. Poster: Henry Ford Health System Quality Expo in Detroit, MI. 11/2010 Jennings DL, Kalus JS, Szandzik E, Hudson M, McCord J, Harpootlian S. Department of Pharmacy Services Heart Failure Quality Measure Collaborative Survey. Poster: Henry Ford Health System Quality Expo in Detroit, MI. 11/2009 PUBLICATIONS: MANUSCIPTS Original Research, Peer-Reviewed: Lekura J, Williams CT, Tita C, Lanfear DE, Jennings DL*. Assessing the potential of email for communicating drug-therapy recommendations to physicians in patients with heart failure and ventricular-assist devices. Accepted in J Pharm Pract 2013

Douglas L. Jennings, PharmD, BCPS 5 Makowski C, Jennings DL, Nemerovski CW, Kalus JS. The impact of a systematically deployed clinical pharmacy service on patient satisfaction. Ann Pharmacother 2013 Jun;47(6):805-10. Jennings DL*, Brewer R, Williams CT. Impact of continuous flow left-ventricular assist device on the pharmacodynamic response to warfarin early after implantation. Ann Pharmacother 2012;46(9):1266-1267. Jennings DL*, Jones MC, Lanfear DE. Assessment of the heart failure pharmacotherapy of patients with continuous flow left-ventricular assist devices. Int J Artif Organs 2012;35(3):177-179. Jennings DL*, Brewer R, Smith C, Williams CT. Clinical Pharmacist Intervention for Patients with Left Ventricular Assist Devices. Ann Pharmacother 2011; Oct;45(10):1311-2. Jennings DL*, McDonnell J, Schillig J. Assessment of the long-term anticoagulation of patients with a continuous flow left-ventricular assist device: A pilot study. J Thorac Cardiovasc Surg 2011;142:e1-e2. Edwin SB, Jennings DL, Kalus JS. An Evaluation of the Early Pharmacodynamic Response after Simultaneous Initiation of Warfarin and Amiodarone. J Clin Pharmcol 2010;50(6):693-8. Jennings DL*, Kalus JS. Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: A meta-analysis. J Clin Pharmacol 2010;50(4):415-21 Hansen L, Jennings DL, Pallares MJ, Thompson A, Garrison K, Wessell AM. Assessment of vitamin K use in the inpatient treatment of excessive anticoagulation. J Pharm Technol 2008;24:137-41. Jennings DL, Ragucci KR, Chumney E, Wessell A. Impact of Pharmacist Intervention on Diabetes Related Quality of Life in an Ambulatory Care Clinic. Pharmacy Practice 2007;5(4):169-173. Jennings DL, Coleman CI, Kalus JS. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A meta-analysis. Diabet Med 2007;24:486 493. Jennings DL, Yagman LA, Petricca JC, O Dell K, Kalus JS. Predictors of early readmission after acute coronary syndrome. Am J Health Syst Pharm 2006;15;63(4): 367-72. Reviews Articles, Peer-Reviewed: Jennings DL*, Schillig J, Chambers R. The Pharmacotherapy of the HeartMate II, a Continuous Flow Left-ventricular Assist Device, in Patients with Advanced Heart Failure: Integration of Disease, Device and Drug. Ann Pharmacother 2010;44:1647-1650. Jennings DL*, Thompson ML. Use of Combination Therapy with a Beta-blocker and a Positive Inotrope in Patients with Advanced Heart Failure. Ann Pharmacother 2009;43:1872-1876. Jennings DL*, Taber D. Utilizing Inhibitors of the Renin-Angiotensin System Early After Renal Transplant. Ann Pharmacother 2008;42:116-20.

Douglas L. Jennings, PharmD, BCPS 6 Jennings DL, Kalus JS, O Dell K. Aldosterone Receptor Antagonism in Heart Failure. Pharmacotherapy 2005;25:1126-33. Case Reports, Peer-Reviewed: Jennings DL*, Nemerovski CW, Kalus JK. Effective anticoagulation for a percutaneous ventricular assist device using a heparin-based purge solution. Accepted in Annals of Pharmacotherapy 2013. Jennings DL*, Williams CT, Morgan JA. Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow leftventricular assist device support. ASAIO J 2013;59:526-7. Jennings DL*, Cabrera R, Wang D, Tita C. Successful treatment of a continuous flow leftventricular assist device thrombosis with eptifibatide. ASAIO J 2012;58:633 635. Dumkow L, Voss J, Peters M, Jennings DL*. Attempted reversal of a life-threatening dabigatranrelated bleed with a prothrombin complex concentrate and fresh frozen plasma. Am J Health Syst Pharm 2012;69(19):1646-1650. Jennings DL*, Nemerovski CW, Khandelwal A. Successful extended use of a percutaneous leftventricular assist device without a heparin-based purge solution. Am J Health Syst Pharm 2010;67:1825-8. Commentaries or Letters to the Editor, Peer-Reviewed: Jennings DL*. Letter by Jennings Regarding Article, Mechanisms of Bleeding and Approach to Patients With Axial-Flow Left Ventricular Assist Devices Circ Heart Fail 2012;5:e102 Nemerovski CW, Dorsch MP, Jennings DL. What should we be fine tuning in acute coronary syndromes dosing of antiplatelet therapy or data presentation? Ann Pharmacother 2011;45:120-2. Reviews, Non-Peer Review: Grycki M, Jennings DL. Determining optimal duration of DAPT after coronary artery stenting. Cardiology Today 2012. Available at: http://www.healio.com/cardiology/vascular- medicine/news/print/cardiology-today/%7b8584797b-8bb0-473d-b55b- 3B1B9E4AFE5E%7D/Determining-optimal-duration-of-DAPT-after-coronary-arterystenting?page=0&Filter To L, Jennings DL. Measuring benefits vs. harm: The complexity of dosing statin therapy. Cardiology Today 2012;15:1. Available at: www.cardiologytoday.com/view.aspx?rid=91064 Jennings DL. Ticagrelor: An Oral, Non-thienopyridine P2Y12 Receptor Antagonist for the Treatment of Acute Coronary Syndromes. Formulary 2010; 45:148 154. Jennings DL, Kalus JS. Tolvaptan: A novel oral vasopressin-2 receptor antagonist for the treatment of acute decompensated heart failure and hyponatremia. Formulary 2008;43:236 249. *corresponding author

Douglas L. Jennings, PharmD, BCPS 7 PUBLICATIONS: BOOK CHAPTERS Jennings DL. Cardiovascular System. In: Godzina LM, Miller DE, Quinn DJ, editors. Pharmacy Certified Technician Training Manual. Lansing, MI: Michigan Pharmacist Association; 2012. P. 425-446. Jennings DL. The Cardiac System. In: Lile JM, Miller DE, Rybicki AL, editors. Pharmacy Certified Technician Training Manual. Lansing, MI: Michigan Pharmacist Association; 2006. P. 255-62. Jennings DL. Cardiac System Disorders. In: Lile JM, Miller DE, Rybicki AL, editors. Pharmacy Certified Technician Training Manual. Lansing, MI: Michigan Pharmacist Association; 2006. P. 263-82. INVITED PRESENTATIONS International: 04/12 2 nd International Cardiovascular Pharmacotherapy Conference Devices and Technology in the Management of Heart Failure Strategies for Managing Resistant Hypertension Combined Atrial Fibrillation and Heart Failure: Challenges in Pharmacotherapy Management ICU Management of End-stage Heart Failure and Mechanical Circulatory Support Therapy Moderator: Session IV Ambulatory Care in Cardiology Prince Sultan Cardiac Center, Pharmacy Department, Riyadh, Saudi Arabia National: 03/12 ASHP Advantage Continuing Education Series Update on Stroke Prevention in Atrial Fibrillation ACPE Accredited Continuing Education Presentation (0.1 CEU) ACPE Number 204-000-12-401-L01P Oklahoma Society of Health-System Pharmacist Annual Meeting, Tulsa OK 04/11 ASHP Advantage Continuing Education Series Considerations for the Prevention of Stroke in Atrial Fibrillation ACPE Accredited Continuing Education Presentation (0.1 CEU) ACPE number 204-000-10-465-L01P Pharmacy Society of Wisconsin Education Conference, Madison WI 09/10 Strategies for Rhythm Control in Atrial Fibrillation ACPE Accredited Continuing Education Presentation (0.1 CEU) ACPE number 0217-9999-10-144-L01-P Mid-Atlantic College of Clinical Pharmacy Meeting, Philadelphia, PN Local: 02/13 Key Updates in Dual Antiplatelet Therapy, Niacin, and Fibrate Therapy ACPE Accredited Continuing Education Presentation (0.1 CEU) ACPE number 0112-0000-13-111-L01-P Michigan Pharmacist Association Annual Convention, Detroit, MI

Douglas L. Jennings, PharmD, BCPS 8 09/10 New Oral Antiplatelet Agents for Acute Coronary Syndromes ACPE Accredited Continuing Education Presentation (0.1 CEU) ACPE number 0124-0000-10-009-L01-P Southeastern Michigan Society of Health-system Pharmacists Meeting, Warren, MI 06/09 Roles for New Anticoagulants in the Treatment of Acute Coronary Syndromes ACPE Accredited Continuing Education Seminar (0.1 CEU) ACPE number 0505-09-016-L01-P 05/07 Updates in Oral Antiplatelet therapy ACPE Accredited Continuing Education Presenation (0.1 CEU) ACPE number 061-999-07-044-L01 The New Drug Update Symposium, Charleston, SC TEACHING EXPERIENCE Didactic Teaching, University-based: 04/09, 03/10, Lecture for Population-based Medication Management (PPR 6290) 03/11 Appropriate Interpretation and Application of Meta-Analyses Third year pharmacy students Wayne State University, Detroit, MI 04/09, 04/10, 04/11 Lecture for Clinical Pharmacokinetics (PPR 7670) Pharmacokinetics and Pharmacodynamics of Digoxin Third year pharmacy students Wayne State University, Detroit, MI 03/08 Lecture for Principles of Pharmacotherapy 4: Cardiology (PHA 4260) Pharmacotherapy of Hyperlipidemia Second year pharmacy students Wayne State University EACPHS, Detroit, MI 03/08 Lecture for Principles of Pharmacotherapy 4: Cardiology (PHA 4260) Pathophysiology of Hyperlipidemia Second year pharmacy students Wayne State University EACPHS, Detroit, MI 09/07 12/07 Section facilitator for Problem-Based Learning (PHA 4010) Facilitated student discussions of simulated patient cases Second year pharmacy students Wayne State University EACPHS, Detroit, MI 10/06 Lecture for Survey of Herbal Medicine (PHMPR-758) Saw Palmetto Second and third year pharmacy students Medical University of South Carolina, Charleston, SC

Douglas L. Jennings, PharmD, BCPS 9 12/05 04/06 Section instructor for Patient Care Lab 4 (PPR 4220) Presented lectures (various topics), taught physical assessment Second year pharmacy students Wayne State University EACPHS, Detroit, MI Didactic Teaching, Hospital-based: 02/2012 Lecture for Pharmacy Resident Grand Rounds Understanding Non-inferiority Study Design: Common Pitfalls Pharmacy residents and students 06/2011 Staff Inservice Anticoagulation Strategies in Patients with Left-ventricular Assist Devices Clinical pharmacists and nurses in the anticoagulation clinics 02/2011 Lecture for ICU/Critical Care Lecture Series Acute Management of Atrial Fibrillation Clinical pharmacists 04/10 Lecture for Cardiovascular Fellow s Noon Conference Updates in Oral Antiplatelet Therapy for Acute Coronary Syndromes Cardiovascular fellows and staff cardiologists 04/10 Staff Inservice Prasugrel and Ticagrelor for the Treatment of Acute Coronary Syndromes Nursing and staff in the Cardiac Catheterization Laboratory 09/09, 09/10 Staff Inservice ECG Rhythm Strip Review for Advanced Cardiac Life Support PGY1 pharmacy residents and fourth-year pharmacy students 08/09 Lecture for ICU/Critical Care Lecture Series Cardiovascular Hemodynamics Clinical Pharmacists 06/09, 03/10 Staff Inservice Optimizing vasopressor use in the Cardiac ICU Nursing and staff in the Cardiac Intensive Care Unit 06/09 Lecture for Cardiovascular Fellow s Noon Conference

Douglas L. Jennings, PharmD, BCPS 10 The Use of Meta-analysis in Cardiovascular Pharmacoepidemiology Cardiovascular fellows and staff cardiologists 04/09 Staff Inservice Role of Inotropes in Managing Acute Decompensated Heart Failure Nurses and staff in the Cardiac Intensive Care Unit 02/09 Lecture for Cardiovascular Fellow s Noon Conference Updates in Anticoagulation Strategies for Acute Coronary Syndromes Cardiovascular fellows and staff cardiologists Experiential Teaching: 03/10 Present Cardiothoracic Intensive Care Unit Primary preceptor for PGY2 Critical Care specialty residents (n=4), Pharmacotherapy residents (n=2), PGY1 Pharmacy Practice residents (4) 12/08 Present Cardiac Intensive Care Unit/Advanced Heart Failure Service Primary preceptor for fourth-year pharmacy students (n=7), PGY1 Pharmacy Practice residents (n=10), PGY2 Critical Care specialty residents (n=12), PGY2 Emergency Medicine Residents (n=1), Pharmacotherapy residents (n=2) 09/07 06/08 Cardiac Intensive Care Unit/General Cardiology Assisted with precepting fourth year pharmacy students (n=4) and PGY1 Pharmacy Practice residents (n=3) 08/06 11/06 Professional Experiential Unit 2 (PEU-2) Preceptor for second year pharmacy students (n=4) Medical University of South Carolina, Charleston, SC Formal Training in Teaching: 08/06 05/07 Academician Preparation Program Medical University of South Carolina, Charleston, SC DEPARTMENT/COMMITTEE SERVICE 02/11 07/13 Senior Faculty, Pharmacist Research Institute for Medication Effectiveness and Safety (PRIME) - Cardiovascular Section, Department of Pharmacy, Henry Ford Hospital 07/07-07/13 Member, Continuum of Care/Ventricular Assist Device Committee, Henry Ford Hospital

Douglas L. Jennings, PharmD, BCPS 11 07/10 03/13 Member, Anticoagulation Subcommittee of the Pharmacy and Therapeutics Committee, Henry Ford Hospital 08/09 07/13 Cardiovascular ICU Collaborative Practice Committee, Departments of Cardiovascular Medicine and Cardiothoracic Surgery, Henry Ford Hospital 07/09 06/10 Co-director, Department of Pharmacy Services Student and Resident Case Conference and Journal Club, Department of Pharmacy Services 12/08 07/13 Clinical Practice Advisory Committee, Department of Pharmacy Services DRUG USE GUIDELINE AND PROTOCOL DEVELOPMENT 06/12 Author; Ticagrelor Drug use Guideline 05/2012 Contributor; Patient Care Services Protocol for High-dose Insulin Therapy for Refractory Beta-blocker and Calcium Channel Blocker Overdose 05/2012 Contributor; Clinical Guideline for Acute Coronary Syndrome 06/2011 Author; Drug-use Guideline for Factor VII in Cardiac Surgery Patients 05/2011 Contributor; Clinical Pathway for the Management of Acute Aortic Pathologies 09/10 Author; Clinical Pathway for the Management of Post-operative Atrial Fibrillation after Cardiac Surgery 06/10 Contributor; Inpatient Warfarin Drug-use Guideline (focus use in patients with left-ventricular assist devices) 06/10 Contributor; Patient Care Services Protocol for Therapeutic Hypothermia in Patients with Sudden Cardiac Arrest 01/10 Contributor; Drug Use Guideline for the Use of Intravenous Nicardipine 01/10 Author; Patient Care Services Protocol for the Anticoagulation with the Impella LP 2.5 Percutaneous Left-ventricular Assist Device 11/09 Author; Drug-use Guideline for Prasugrel PROFESSIONAL ACTIVITIES AND FUNCTIONS ACCP Service 10/14 Chair: Cardiology PRN 10/13 Chair-elect: Cardiology PRN 08/13 Referee: Student Travel Award for the 2013 Annual Meeting 08/13 Judging committee for Best Resident/Fellow Poster for the 2013 Annual Meeting 08/13 Referee: Student and Resident CV review service 07/13 Referee: Abstracts for the 2013 Annual Meeting 04/13 Referee: ACCP 2013 Clinical Reasoning Series: Pain, Agitation, and Delirium in the Intensive Care Unit 08/13 Chair: Fundraising Committee, Cardiology PRN 10/12 Chair: Expenditures Committee, Cardiology PRN 10/12 Secretary/Treasurer: Cardiology PRN 08/12 Referee: Student Travel Award for the 2012 Annual Meeting 08/12 Judging committee for Best Student Poster for the 2012 Annual Meeting 08/12 Referee: Student and Resident CV review service 08/12 Chair: Fundraising Committee, Cardiology PRN

Douglas L. Jennings, PharmD, BCPS 12 07/12 Referee: Abstracts for the 2012 Annual Meeting 08/11 Chair: Fundraising Committee, Cardiology PRN 01/09 Cardiology PRN Fundraiser Task Force Member 07/06 Present Full Member, Cardiology PRN Member Referee Experience 07/12 Posters/abstracts for the 2013 ASHP Midyear Meeting 02/13 The American Heart Journal 11/12 International Journal of Artificial Organs 07/12 Posters/abstracts for the 2012 ASHP Midyear Meeting 03/11 Current Medical Research and Opinion 09/10 The Journal of Clinical Pharmacology 07/10 Posters/abstracts for the 2010 ASHP Midyear Meeting 04/10 The Lancet 04/10 American Journal of Health-System Pharmacy 06/09 American Journal of Cardiology 07/07 Annals of Pharmacotherapy Membership/Leadership 03/12 Present Faculty Mentor, International Society of Heart and Lung Transplantation 08/12 Present International Society of Heart and Lung Transplantation Member 08/11 Present American College of Cardiology Member 04/10 04/11 American Heart Association Member; Council on Arteriosclerosis, Thrombosis and Vascular Biology 03/10 Present South-eastern Society of Health-System Pharmacists (SMSHP) member 05/05 Present American Society of Health-System Pharmacists (ASHP) Member MENTORING 07/12 06/13 Primary preceptor, PGY1 resident project; Epidemiology and outcomes of anemia in patients with continuous-flow left-ventricular assist devices. 07/12 06/13 Primary preceptor, PGY1 resident project; Predictors of infection in patients with cardiogenic shock after acute myocardial infarction. 07/12 06/13 Primary preceptor, P4 student project; Safety of anticoagulation in patients with continuous-flow left-ventricular assist devices. 07/12 06/13 Primary preceptor, P4 student project; Outcomes of chronic antimicrobial suppressive therapy in patients with left-ventricular assist devices. 07/11 06/12 Co-preceptor, PGY1 resident project; Costs associated with diagnostic strategies in heparin-induced thrombocytopenia. 07/11 06/12 Primary preceptor, P4 student project; Pharmacokinetics of antimicrobial agents in patients with left-ventricular assist devices. 07/11 06/12 Primary preceptor, PGY2 resident project; Assessment of long-term clinical outcomes in patients with post-operative atrial fibrillation. 07/11 06/12 Primary preceptor, PGY1 resident project; Acute hemodynamic effects of oral sildenafil in patients with heart failure and pulmonary artery hypertension. 07/10 06/11 Primary preceptor, PGY1 resident MUE; Assessment of antiplatelet and anticoagulant use in the cardiac catheterization laboratory. 05/10 04/11 Primary preceptor, P4 student project; Assessment of the adjunct

Douglas L. Jennings, PharmD, BCPS 13 pharmacotherapy of patients undergoing rescue PCI in the setting of STelevation myocardial infarction 05/10 04/11 Primary preceptor, P4 student project; Assessment of the pharmacotherapy of left-ventricular assist devices 07/09 06/10 Primary preceptor, PGY1 resident project; Impact of pharmacist discharge counseling on rates of thienopyridine adherence after coronary artery stenting 07/09 06/10 Co-preceptor, PGY1 resident project; Cost and outcomes of infections in patients with left-ventricular assist devices 07/09 05/10 Primary Preceptor, P4 student project; Safety and efficacy of outpatient anticoagulation in patients with a continuous-flow rotary assist device HONORS AND AWARDS 04/13 International Travelling Scholarship Award, International Society of Heart and Lung Transplantation. Provided $6,000 funding for Dr. Rochelle Gellalty to travel to Henry Ford from Australia to complete research related to mechanical circulatory support 06/12 Preceptor of the Year, Henry Ford Hospital Residency Program 05/05 The Kappa Psi Pharmaceutical Fraternity Detroit Graduate Chapter Award, which is given to the graduating pharmacy student with the highest G.P.A. 05/05 The Substance Abuse Student Educator Pharmacy Award LICENSES AND CERTIFICATIONS 06/05 Michigan Registered Pharmacist License 06/05 Michigan Controlled Substance License 09/06 South Carolina Pharmacist License 07/06 BLS/ACLS certified by the American Heart Association 12/08 Board Certified Pharmacotherapy Specialist (BCPS) 01/10 Added Qualifications (AQ) in Cardiology